Trial Search Results
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
This is a 5-year, longitudinal, observational study of patients with PBC designed to specifically address important clinical questions that remain incompletely answered from registration trials. In addition to the study database, a bio specimen repository will also be included so that translational studies of genomics and biomarkers of response may be performed.
Stanford is currently accepting patients for this trial.
Target PharmaSolutions, Inc.
- Adult patients (age 18 or older) being treated or managed for PBC
- Inability to provide written informed consent
- Simultaneous enrollment in another prospective registry or clinical trial or study
where PBC treatment outcomes are reported, except where approved or conducted as an
adjunct project of TARGET-PBC
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study